P8IP
SAGE

Pier 88 Investment Partners’s Sage Therapeutics SAGE Stock Holding History

Pier 88 Investment Partners’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-4,930
Closed -$692K – 99
2019
Q3 		$692K Buy
4,930
+825
+20% +$138K 0.27% 60
2019
Q2 		$752K Hold
4,105
– – 0.32% 53
2019
Q1 		$653K Buy
4,105
+1,620
+65% +$235K 0.3% 65
2018
Q4 		$238K Sell
2,485
-1,735
-41% -$199K 0.12% 73
2018
Q3 		$596K Buy
4,220
+2,485
+143% +$384K 0.26% 53
2018
Q2 		$272K Buy
+1,735
New +$272K 0.13% 72

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Pier 88 Investment Partners's SAGE Position: Q4 2019 in Review

Pier 88 Investment Partners sold out of Sage Therapeutics (SAGE) in Q4 2019, closing a stake of 4,930 shares — an estimated $692K sold.

Pier 88 Investment Partners first reported a position in SAGE in Q2 2018 and held it in 6 quarters. The position peaked at $752K in Q2 2019. 267 funds tracked by Wall St. Rank hold SAGE as of Q4 2019.

  • Pier 88 Investment Partners reported no remaining Sage Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Pier 88 Investment Partners sold 4,930 Sage Therapeutics shares in Q4 2019, an estimated $692K.
  • Pier 88 Investment Partners first reported a position in Sage Therapeutics in Q2 2018 and held it in 6 quarters.
  • Pier 88 Investment Partners's Sage Therapeutics position peaked at $752K in Q2 2019.
  • 267 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2019.

Based on Pier 88 Investment Partners's 13F filing for Q4 2019, filed 14 Feb 2020.